S

SuppreMol GmbH

10001 employees

SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Health Care

Date founded

2002

Funding rounds raised

Total raised

$25M

from 18 investors over 18 rounds

S

SuppreMol GmbH raised $12M on May 21, 2013

Investors: Santoholding, BioMedPartners and MIG Capital

S

SuppreMol GmbH raised $8.2M on September 1, 2012

Investors: MIG Capital

S

SuppreMol GmbH raised $21M on December 17, 2010

Investors: Santoholding, Bayern Kapital GmbH, BioMedPartners, KfW and MIG Capital

S

SuppreMol GmbH raised $25M on July 15, 2008

Investors: Santoholding, Max Planck Institute for Astronomy, Bayern Kapital GmbH, KfW, BioMedPartners and MIG Capital

S

SuppreMol GmbH raised $5.2M on May 24, 2006

Investors: Zambon, KfW and Bayern Kapital GmbH

FAQ